Soft Tissue Biologics Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
All the vital news, analysis, and commentary curated by our industry experts.
Soft Tissue Biologics Pipeline Market Report Overview
Soft Tissue Biologics are used in surgical procedures to replace, reinforce, or repair tendons or ligaments that have been torn or damaged in the human body. This model focuses on the repair of the anterior cruciate ligament (ACL), posterior cruciate ligament (PCL), rotator cuff, and Achilles tendon. Other indications include medial collateral ligament (MCL), lateral collateral ligament (LCL), medial patellofemoral ligament (MPFL), ulnar collateral ligament (UCL), flexor tendon, and hip flexor repair. They can be either tendon grafts/reinforcements or tendon wrapping products.
|Key Segments||· Synthetic Graft
|Key Territories||· The US
|Key Regulatory Paths||· 510(k)
|Leading Companies||· Acuitive Technologies Inc
· Anika Therapeutics Inc
· BioGend Therapeutics Co Ltd
· Colorado Therapeutics, LLC
· Columbia University
· Core Essence Orthopaedics, LLC
· Georgia Institute of Technology
|Enquire & Decide||Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.|
Soft Tissue Biologics Pipeline Market by Segments
The key segments in the soft tissue biologics pipeline market are Synthetic Graft, Xerograft, and Collagen. As of August 2023, Synthetic Graft has the highest number of pipeline products.
Soft Tissue Biologics Pipeline Market Analysis by Segments, 2023 (%)
Buy Full Report for More Insights into the Soft Tissue Biologics Pipeline Market Segments or Download a Free Sample Report
Soft Tissue Biologics Pipeline Market Segmentation by Territories
Some of the key territories in the Soft Tissue Biologics Pipeline Market are the US, China, Europe, Vietnam, Malaysia, Philippines, and Singapore. As of August 2023, the US has the highest number of pipeline products.
Soft Tissue Biologics Pipeline Market Analysis by Territories, 2023 (%)
Buy Full Report for More Territory Insights into the Soft Tissue Biologics Pipeline Market
Download a Free Sample Report
Soft Tissue Biologics Pipeline Market Segmentation by Regulatory Paths
Some of the key regulatory paths in the Soft Tissue Biologics pipeline market are 510(k), NMPA, CE, HAS, MDA, and BLA. As of August 2023, 510(k) is the most followed path for pipeline products in the market.
Soft Tissue Biologics Pipeline Market Analysis by Regulatory Paths, 2023 (%)
Buy Full Report for More Regulatory Path Insights into the Soft Tissue Biologics Pipeline Market or
Download a Free Sample Report
Soft Tissue Biologics Pipeline Market – Competitive Landscape
Some of the key companies in the Soft Tissue Biologics pipeline market are Acuitive Technologies Inc, Anika Therapeutics Inc, BioGend Therapeutics Co Ltd, Colorado Therapeutics, LLC, Columbia University, Core Essence Orthopaedics, LLC, Georgia Institute of Technology among others
Anika Therapeutics Inc: It offers solutions for ortho-biologics, dermal, ophthalmic, surgical, and veterinary applications. Its major products include human and veterinary visco-supplementation, Joint implants, instrumentation devices, joint replacement solutions, regenerative and orthopedic surgical therapies, bone repair therapy, advanced wound care, and ophthalmic products. Its products are made from hyaluronic acid (HA) based on technology, HYAFF, which is a solid form of HA.
Columbia University: CU conducts research through its research institutes and centers in the areas of natural and bio-medical sciences, social sciences, and humanities. Meanwhile, the university provides educational services and courses through its schools, departments, faculties, centers, and institutes. It also provides undergraduate and graduate courses in various disciplines including architecture, planning and preservation, arts, sciences, social sciences, dental medicine, engineering, law, social work, nursing and public health, among others.
Soft Tissue Biologics Pipeline Market Analysis by Companies, 2023
Buy Full Report for More Insights into the Leading Companies in the Soft Tissue Biologics Pipeline Market
Download a Free Sample Report
Segments Covered in the Report
Soft Tissue Biologics Pipeline Market Segments Outlook
- Synthetic Graft
Soft Tissue Biologics Pipeline Market Territories Outlook
- The US
Soft Tissue Biologics Pipeline Market Regulatory Paths Outlook
This report provides:
- Extensive coverage of the Soft Tissue Biologics under development.
- The report reviews details of major pipeline products which include product description, licensing and collaboration details and other developmental activities.
- The report reviews the major players involved in the development of Soft Tissue Biologics and lists all their pipeline projects.
- The coverage of pipeline products is based on various stages of development ranging from early development to approved/issued stage.
- The report provides key clinical trial data of ongoing trials specific to pipeline products.
- Recent developments in the segment/industry.
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies.
- Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
- Identify and understand important and diverse types of Soft Tissue Biologics under development.
- Develop market-entry and market-expansion strategies.
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
- In-depth analysis of the product’s current stage of development, territory, and estimated launch date
Anika Therapeutics Inc
BioGend Therapeutics Co Ltd
Colorado Therapeutics, LLC
Core Essence Orthopaedics, LLC
Georgia Institute of Technology
New York R&D Center for Translational Medicine and Therapeutics Inc
Novadip Biosciences SA
Nutech Medical Inc
OHSU Knight Cancer Institute
Osteopore International Pte Ltd
Shandong Junxiu Biotechnology Co Ltd
STEL Technologies LLC
Tissue Regenix Group PLC
University of Bielefeld
University of Minnesota
University of Missouri
Table of Contents
|1 Table of Contents 3
|1.1 List of Tables 5
|1.2 List of Figures 7
2 Introduction 8
2.1 Soft Tissue Biologics Overview 8
3 Products under Development 9
3.1 Soft Tissue Biologics – Pipeline Products by Stage of Development 9
3.2 Soft Tissue Biologics – Pipeline Products by Segment 10
3.3 Soft Tissue Biologics – Pipeline Products by Territory 11
3.4 Soft Tissue Biologics – Pipeline Products by Regulatory Path 12
3.5 Soft Tissue Biologics – Pipeline Products by Estimated Approval Date 13
3.6 Soft Tissue Biologics – Ongoing Clinical Trials 14
4 Soft Tissue Biologics – Pipeline Products under Development by Companies 15
4.1 Soft Tissue Biologics Companies – Pipeline Products by Stage of Development 15
4.2 Soft Tissue Biologics – Pipeline Products by Stage of Development 16
5 Soft Tissue Biologics Companies and Product Overview 17
5.1 Acuitive Technologies Inc Company Overview 17
5.1.1 Acuitive Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 17
5.2 Anika Therapeutics Inc Company Overview 18
5.2.1 Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 18
5.3 BioGend Therapeutics Co Ltd Company Overview 20
5.3.1 BioGend Therapeutics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 20
5.4 Colorado Therapeutics, LLC Company Overview 23
5.4.1 Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 23
5.5 Columbia University Company Overview 26
5.5.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 26
5.6 Core Essence Orthopaedics, LLC Company Overview 27
5.6.1 Core Essence Orthopaedics, LLC Pipeline Products & Ongoing Clinical Trials Overview 27
5.7 Georgia Institute of Technology Company Overview 28
5.7.1 Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 28
5.8 New York R&D Center for Translational Medicine and Therapeutics Inc Company Overview 29
5.8.1 New York R&D Center for Translational Medicine and Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 29
5.9 Novadip Biosciences SA Company Overview 30
5.9.1 Novadip Biosciences SA Pipeline Products & Ongoing Clinical Trials Overview 30
5.10 Nutech Medical Inc Company Overview 31
5.10.1 Nutech Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 31
5.11 OHSU Knight Cancer Institute Company Overview 34
5.11.1 OHSU Knight Cancer Institute Pipeline Products & Ongoing Clinical Trials Overview 34
5.12 Osteopore International Pte Ltd Company Overview 35
5.12.1 Osteopore International Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 35
5.13 Shandong Junxiu Biotechnology Co Ltd Company Overview 36
5.13.1 Shandong Junxiu Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 36
5.14 STEL Technologies LLC Company Overview 38
5.14.1 STEL Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 38
5.15 Tissue Regenix Group PLC Company Overview 39
5.15.1 Tissue Regenix Group PLC Pipeline Products & Ongoing Clinical Trials Overview 39
5.16 University of Bielefeld Company Overview 42
5.16.1 University of Bielefeld Pipeline Products & Ongoing Clinical Trials Overview 42
5.17 University of Minnesota Company Overview 43
5.17.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 43
5.18 University of Missouri Company Overview 44
5.18.1 University of Missouri Pipeline Products & Ongoing Clinical Trials Overview 44
6 Soft Tissue Biologics- Recent Developments 45
6.1 Jan 23, 2023: Regenative Labs and Dr. Michael Lavor announce case study demonstrating novel application of umbilical cord flowable tissue allografts in decubitus ulcers 45
7 Appendix 46
7.1 Methodology 46
7.2 About GlobalData 49
7.3 Contact Us 49
7.4 Disclaimer 49
Frequently asked questions
Which is the leading segment in the Soft Tissue Biologics pipeline market?
Synthetic Graft is the leading segment in the Soft Tissue Biologics pipeline market as of August 2023.
Which territory has the highest number of pipeline products in the Soft Tissue Biologics pipeline market?
As of August 2023, the US has the highest number of products in the Soft Tissue Biologics pipeline market.
Which is the most followed regulatory pathway in the Soft Tissue Biologics pipeline market?
As of August 2023, 510(k) is the most followed pathway for products in the Soft Tissue Biologics pipeline market.
Who are the major companies operating in the Soft Tissue Biologics pipeline market?
Some of the key companies in the Soft Tissue Biologics pipeline market are Acuitive Technologies Inc, Anika Therapeutics Inc, BioGend Therapeutics Co Ltd, Colorado Therapeutics, LLC, Columbia University, Core Essence Orthopaedics, LLC, and Georgia Institute of Technology
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Business Intelligence & Marketing Manager, SAL Heavy Lift
“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.
GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”
Market Analyst & Management, Liebherr-Werk
“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”
Head of Key Accounts, Saab AB
Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.
Marketing Intelligence Manager, Portugal Foods
Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.
Head of Customer Insight and Research, Standard Chartered
Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.
I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.
I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.
Head of Consumer Sensory Insights, Givaudan
“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.
Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”
Senior Account Manager, TSYS
GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise. The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.
I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.
One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.